NCT04688593 Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
| NCT ID | NCT04688593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Waldemar Link GmbH & Co. KG |
| Condition | Osteoarthritis, Hip |
| Study Type | OBSERVATIONAL |
| Enrollment | 520 participants |
| Start Date | 2021-05-04 |
| Primary Completion | 2036-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 520 participants in total. It began in 2021-05-04 with a primary completion date of 2036-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Eligibility Criteria
Inclusion Criteria: * Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link * Age ≥ 18 years * Fully signed patient informed cons Exclusion Criteria: * Revisions * Body Mass Index (BMI) ≥ 40 kg/m² * Patient who is foreseeable not able to understand the study and the study-related circumstances * Patients who is foreseeable non-compliant to the treatment and the follow-ups * Pregnant or breast-feeding women * Prisoner
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04688593 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis, Hip. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04688593 currently recruiting?
Yes, NCT04688593 is actively recruiting participants. Contact the research team at l.skottke@link-ortho.com for enrollment information.
Where is the NCT04688593 trial being conducted?
This trial is being conducted at Kiel, Germany, Kirkcaldy, United Kingdom.
Who is sponsoring the NCT04688593 clinical trial?
NCT04688593 is sponsored by Waldemar Link GmbH & Co. KG. The trial plans to enroll 520 participants.